Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49230, first published .
Pharmacogenetics Clinical Decision Support Systems for Primary Care in England: Co-Design Study

Pharmacogenetics Clinical Decision Support Systems for Primary Care in England: Co-Design Study

Pharmacogenetics Clinical Decision Support Systems for Primary Care in England: Co-Design Study

Journals

  1. McDermott J, Burke K, Fullerton N, O’Sullivan J, Alex A, Ingham A, Sharma V, Godfrey N, Odudu A, Syed T, Stevens A, Beynon R, Greaves N, Akam D, Mirza S, Wilson P, Wright S, Payne K, Newman W. Pre-emptive pharmacogenetic testing in the acute hospital setting: a cross-sectional study. QJM: An International Journal of Medicine 2025;118(3):154 View
  2. Butruille J, Cirnat N, Alaoui M, Saracco J, Cousein E, Chaniaud N. Pharmaceutical Analysis of Inpatient Prescriptions: Systematic Observation of Hospital Pharmacists’ Practices in the Early User-Centered Design Phase. JMIR Human Factors 2025;12:e65959 View
  3. Sharma V, McDermott J, Keen J, McIntyre B, Watson S, Newman W. Designing an interoperable solution to support pharmacogenomic-guided prescribing in primary care: an implementer report. BMJ Health & Care Informatics 2025;32(1):e101163 View
  4. McDermott J, Sharma V, Keen J, Newman W. Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes. Annals of Human Genetics 2025;89(5):398 View
  5. Roelofsen A, Kreeftenberg L, van El C, Henneman L, Rigter T, Sie D, Bet P, Cornel M. Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data. Pharmacogenomics 2025;26(5-6):143 View
  6. McDermott J, Tsakiroglou M, Newman W, Pirmohamed M. Pharmacogenomics in the UK National Health Service: Progress towards implementation. British Journal of Clinical Pharmacology 2025;91(8):2241 View
  7. McDermott J, Shoaib A, Keen J, Skitterall C, Sharma V, Newman W. How to implement pre-emptive pharmacogenetic testing in the acute hospital setting. Pharmacogenomics 2025;26(10-12):385 View
  8. Jayathilaka N, Weththasinghe A, Ganamurali N, Sabarathinam S. Integrating Pharmacogenomic Insights in GLP‐1 Receptor Agonist Therapy: Direct GLP1R and ARRB1 Variants and Indirect CYP2D6 Influences in Personalized Obesity Management. Clinical Pharmacology in Drug Development 2025 View